Tag: ESC
Pooled analysis of over 18,000 participants supports benefits of finerenone across cardio-kidney-metabolic conditions
A pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascul...
New ESC guidelines combine peripheral arterial and aortic diseases for first time, emphasising interconnectivity of whole arterial system
The European Society of Cardiology (ESC) has today published its 2024 guidelines for the management ...
Talking therapy associated with reduced risk of cardiovascular disease
Effective management of depression through psychological therapy is associated with a lower likeliho...
New consensus statement will take into account latest clinical trial evidence on renal denervation
A new consensus statement—in development from the European Society of Cardiology (ESC) and the ...
“No red flags” for ticagrelor monotherapy according to stent type
George Dangas (New York, USA) discusses the results of the TWILIGHT-Stent trial, presented at the...
Morning exercise is the key to a good night’s sleep after heart bypass surgery
Patients who have trouble sleeping after heart bypass surgery should go for a morning walk, accord...
ESC to stream the latest science in heart failure
The European Society of Cardiology (ESC) has announced that the HFA Discoveries online event will be...
COVID-19: Both ACC and ESC urge patients to seek help if they experience symptoms of a myocardial infarction
In separate statements, the European Society of Cardiology (ESC) and American College of Cardiol...
Cardiologists share COVID-19 insights
Cardiologists from across Europe have shared their experience of having treated COVID-19 patients, i...
BBC Newsnight investigation of EXCEL prompts EACTS to reject 2018 European recommendations on left main disease
The European Association of Cardio-Thoracic Surgery (EACTS) has withdrawn its support ...
We need to embrace digital education and adapt it to improve patient care—reflections from the ESC
Recent years have seen many advances in education for cardiologists, but little attention has be...
Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised in six months
Nearly a quarter of patients with chronic ischaemic cardiovascular disease are dead o...
ESC calls for sex-specific drug dosages of cardiovascular medication
Sex-specific cardiovascular drug dosages are needed to reduce adverse reactions in women, accord...
New research indicates “harmless” painkillers are associated with an increased risk of cardiac arrest
According to a study published in European Heart Journal–Cardiovascular Pharmacotherapy, painkil...
Clinical trial rules should protect patients and results not operational details, says ESC
Rules governing the conduct of clinical trials are failing to produce the intended benefits for pati...
ESC 2016: Bare metal stents inferior to drug-eluting stents for saphenous vein graft PCI at three years
Data from a new study, BASKET-SAVAGE, indicate that patients who receive a drug-eluting stent wh...
ESC 2016: Less unnecessary angiography with functional imaging
A study presented at the 2016 European Society of Cardiology (ESC) congress (27–31 August, Rome,...
ESC 2016: Adding N-acetylcysteine to glyceryl trinitrate reduces infarct size by a third
A placebo-controlled, double-blind trial—NACIAM (N-acetylcysteine in acute myocardial infarction...
ESC 2016: Rethink of ICD implantation in non-ischaemic heart failure may be on the cards
Implantable cardioverter-defibrillators (ICDs) do not improve overall long-term survival compared to...
ESC 2016: First head-to-head comparisons of prasugrel and ticagrelor shows no significant differences
The initial results of the first randomised controlled trial—PRAGUE 18—to directly compare prasu...
ESC 2016: Society welcomes the Pope to the congress
Pope Francis visited the 2016 European Society of Cardiology (ESC) congress (27-31 August, Rome, Ita...
ESC 2016: Off-hours STEMI patients do not have worse outcomes
A new analysis of data from the CHAMPION PHOENIX (Cangrelor versus standard therapy to achieve o...
ESC 2016: Drug-eluting stents are still preferred despite no long-term survival advantage over bare metal stents
The results of NORSTENT (Norwegian coronary stent trial) indicate that second-generation drug-el...
ESC launches paper on tackling cardiac toxicity of anticancer therapies
The European Society of Cardiology has launched a novel position paper, under the auspices of its Co...
ESC and EACTS launch first collaborative atrial fibrillation guidelines
The first European Society of Cardiology (ESC) Guidelines on Atrial Fibrillation developed in collab...
Philips to showcase “full suite” of cardiology solutions for diagnosis and treatment at ESC
A press release reports that Royal Philips will be showcasing its latest in advanced integrated ...
